Mine

Nature is responsible for 50% of all medicines and 25% of agrochemicals, yet this is achieved with only 10% of the bacterial genome, as most bacterial pathways remain inactive when cultivated in the lab. ErebaGen’s Mine platform activates these pathways through genetic engineering to create libraries of bioactive natural compounds. Key advantages of our platform include:

• Bioinformatics to prevent the rediscovery of known compounds
• Use of transcriptional activators for simple purification and production of compounds in mg/L quantities for early screening
• Automation that enables the creation of up to 200 compounds per month
• Hit rates of 25% with narrow-spectrum activity in industrial screens in collaboration with an international agritech partner
• Scalable with fermentation